Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Aeolus commences study of AEOL-10150 as a countermeasure to radiation

Sep. 10, 2009

Lilly describes kappa opioid receptor antagonists for the treatment of ethanol use disorders

Sep. 2, 2009

Carisbamate suppresses alcohol intake in rat model of alcoholism

Aug. 27, 2009

Riluzole modulates alcohol self-administration and withdrawal in preclinical studies

Aug. 26, 2009

GSK describes novel mGlu5 receptor antagonists for substance abuse

Aug. 25, 2009

Carisbamate reduces alcohol preference and intake in alcohol-preferring rats

Aug. 7, 2009

Janssen discloses NPY Y2 antagonists for the treatment of alcoholism

Aug. 5, 2009

Gabapentin is efficacious in treatment of cannabis dependence and withdrawal

Aug. 4, 2009

NIAID initiates trial evaluating AEOL-10150 for treating radiation exposure

June 8, 2009

Cleveland BioLabs concludes initial phase I safety study for CBLB-502

June 4, 2009

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026